LSV Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,900
Closed -$1.5M 874
2023
Q4
$1.5M Sell
4,900
-45,879
-90% -$12.4M ﹤0.01% 645
2023
Q3
$12.3M Sell
50,779
-3,436
-6% -$879K 0.03% 393
2023
Q2
$13M Sell
54,215
-14
-0% -$2.91K 0.03% 389
2023
Q1
$10.2M Buy
54,229
+53,222
+5,285% +$11M 0.02% 419
2022
Q4
$214K Buy
+1,007
New +$201K ﹤0.01% 785
2020
Q2
Sell
-1,900
Closed -$139K 1005
2020
Q1
$139K Buy
+1,900
New +$165K ﹤0.01% 881
2019
Q1
Sell
-20,200
Closed -$1.07M 963
2018
Q4
$1.07M Sell
20,200
-14,081
-41% -$773K ﹤0.01% 774
2018
Q3
$2.05M Sell
34,281
-8,500
-20% -$465K ﹤0.01% 722
2018
Q2
$1.84M Hold
42,781
﹤0.01% 743
2018
Q1
$1.49M Buy
42,781
+28,244
+194% +$1.03M ﹤0.01% 768
2017
Q4
$527K Buy
+14,537
New +$510K ﹤0.01% 848

Other funds holding MEDP

LSV Asset Management's MEDP Position: Q1 2024 in Review

LSV Asset Management sold out of Medpace (MEDP) in Q1 2024, closing a stake of 4,900 shares — an estimated $1.5M sold.

LSV Asset Management first reported a position in MEDP in Q4 2017 and held it in 11 quarters. The position peaked at $13M in Q2 2023. 596 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • LSV Asset Management reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • LSV Asset Management sold 4,900 Medpace shares in Q1 2024, an estimated $1.5M.
  • LSV Asset Management first reported a position in Medpace in Q4 2017 and held it in 11 quarters.
  • LSV Asset Management's Medpace position peaked at $13M in Q2 2023.
  • 596 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on LSV Asset Management's 13F filing for Q1 2024, filed 6 May 2024.